Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV

Suggested Citation

Ogbe A., Pace M., Bittaye M., Tipoe T., Adele S., Alagaratnam J., Aley P.K., Ansari M.A., Bara A., Broadhead S., Brown A., Brown H., Cappuccini F., Cinardo P., Dejnirattisai W., Ewer K.J., Fok H., Folegatti P.M., Fowler J., Godfrey L., Goodman A.L., Jackson B., Jenkin D., Jones M., Longet S., Makinson R.A., Marchevsky N.G., Mathew M., Mazzella A., Mujadidi Y.F., Parolini L., Petersen C., Plested E., Pollock K.M., Rajeswaran T., Ramasamy M.N., Rhead S., Robinson H., Robinson N., Sanders H., Serrano S., Tipton T., Waters A., Zacharopoulou P., Barnes E., Dunachie S., Goulder P., Klenerman P., Screaton G.R., Winston A., Hill A.V.S., Gilbert S.C., Carroll M., Pollard A.J., Fidler S., Fox J., Lambe T., Frater J. Durability of ChAdOx1 nCoV-19 vaccination in people living with HIV. JCI Insight Vol.7 No.7 (2022). doi:10.1172/jci.insight.157031 Retrieved from: https://repository.li.mahidol.ac.th/handle/123456789/85959

Availability

Collections